| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 8, 2026 | Innovation isn't enough: Biopharma needs urgent reinvention, PwC says | Attempting to scry the future of the pharmaceutical industry, professional services juggernaut PwC has laid out lofty ambitions for what it believes drugmakers could achieve by 2035—as well as the steps those companies should take in 2026 t... |
| Dec 31, 2025 | В США кандидаты наук не могут найти работу из-за спада в развитии Бостонского биотехнологического центра | Газета Wall Street Journal сообщает, что некогда процветающий биотехнологический сектор Бостона переживает резкий спад, в результате чего молодые доктора наук испытывают трудности с поиском работы. Они сталкиваются с сокращением венчурного ... |
| Oct 13, 2025 | Dublin’s Meta-Flux raises €1.8M to decode biology with AI | Meta-Flux, a Dublin-based biotech startup, has raised €1.8M in Seed funding to expand its decision-support platform for preclinical drug development, bridging the gap between preclinical research and clinical application.
Acting as an “AI b... |
| Feb 6, 2025 | TOOTRiS Partners with Core by Biocom California to Offer Child Care Benefits to Life Science Professionals | Biocom California & TOOTRiS team up
We believe Child Care should be viewed as a retention, equity and business issue—not just a family issue”
— Tim Scott, President and CEO of Biocom California
SAN DIEGO, CA, UNITED STATES, February 6, ... |
| Sep 13, 2024 | The New Wave of Healthcare Innovation: Leaders Shaping the Future | The healthcare landscape is evolving. Two recent appointments highlight this shift. Closed Loop Medicine and Highlander Health are at the forefront, steering the ship toward a more personalized and efficient future. Closed Loop Medicine, a ... |
| Sep 11, 2024 | Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors | Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones
London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine le... |
| Jul 9, 2024 | Introducing our New MassBioEdge Preferred Partner in Lab Operations: Service Insight | CAMBRIDGE, Mass. and MADISON, Conn., July 9, 2024 /PRNewswire/ -- MassBio is proud to announce Service Insight, a leading innovator in AIoT powered asset management and monitoring solutions, as the Preferred Lab Operations Platform Partner ... |
| Apr 11, 2023 | Massachusetts Life Sciences Week Focuses Spotlight on Commonwealth’s Global Leadership | April 24-28 to be celebrated as Life Sciences Week in Massachusetts; Three marquee convenings set stage to showcase the Massachusetts ecosystem’s global impact
Being able to formally recognize the lifesaving work our member companies and pa... |
| Apr 4, 2023 | RCH Solutions To Host Networking Event at Bio-IT World 2023 | We look forward to sharing our knowledge and experiences with the attendees of Bio-IT World 2023, an event that provides an excellent opportunity for us to connect with our colleagues and industry peers, and showcase how RCH can help organi... |
| Mar 21, 2023 | MassBio Convening | The Worker Empowerment Cabinet collaborated with the Mayor’s Office and the Massachusetts Biotechnology Council (MassBio) to convene a summit of life science companies, education and training providers, and community organizations at Southl... |
| Feb 24, 2023 | RCH Solutions Joins MassBio, The Boston-area Based Industry Organization Dedicated to Advancing Leadership within the Life Sciences | RCH Solutions (RCH), a global provider of Bio-IT computing expertise, has joined Boston-area non-profit, MassBio, dedicated to advancing leadership within the Life Sciences. With a large and growing presence throughout New England, RCH Solu... |
| Feb 23, 2023 | RCH Solutions Joins MassBio, The Boston-area Based Industry Organization Dedicated to Advancing Leadership within the Life Sciences | RCH Solutions provides expert Bio-IT services to the Life Sciences. "We pride ourselves on our ability to prioritize the delivery of results over the fulfillment of service levels, and we look forward to sharing the expertise and insig... |
| Jan 9, 2023 | Healthcare Hires of Note | ProofPilot, a digital protocol automation platform for clinical trials, has added Bernadette Tosti to its executive leadership team in the role of chief product officer this week. Tosti has more than 15 years of experience in the digital cl... |
| Dec 15, 2022 | The week in agrifoodtech: NotCo scores $70m, HealthKart’s mega-round, new funding for Winter Farm | Another week, another funding round for Chilean foodtech startup NotCo. But it wasn’t the only company to land funding during this downturn. Nutrition platform HealthKart secured a mega-round, while indoor farming and restaurant tech both s... |
| Oct 6, 2022 | Asymmetrex® Discusses Impact of New Technologies for Stem Cell Dosage Determination on Outsourcing for Stem Cell Clinical Trials, Gene Therapy Clinical Trials, and Pharma | Asymmetrex® Presents at OCTNE 2022 in Boston on October 12 Stem cell dosage determination will transform the stem cell clinical trials industry, including its outsourcing.
BOSTON (PRWEB) October 06, 2022
The OCTNE 2022 conference, taking pl... |
| Sep 20, 2022 | Asymmetrex® Gives First Cell Culture Core Facility Introduction to Online Rapid Stem Cell Counting in the Institute for Applied Life Sciences at UMassAmherst | September 20 Presentation on Technology for Rapid Stem Cell Counting After UMassAmherst in-person, the first national webinar in the core facility introduction series is scheduled a week later on September 27!
BOSTON (PRWEB) September 20, 2... |
| Sep 13, 2022 | Asymmetrex’s Introduction of Online Calculators for Determination of the Dosage of Therapeutic Stem Cells Announced as a Reformation in Stem Cell Science and Medicine | Console page from Asymmetrex® online calculator portal for determining the dosage of umbilical cord blood stem cells ...introduction of online rapid stem cell-counting calculators is the start of a reformation in stem cell science and medic... |
| Aug 4, 2022 | Asymmetrex® Interviewed by Tech Company News About Plans to Introduce Online Rapid-Counting Calculators for Quantifying Therapeutic Tissue Stem Cells | Preview of an online rapid stem cell-counting calculator portal page Counting tissue stem cells accurately and fast is something stem cell science and stem cell medicine have needed for a very long time. It’s here now,...
BOSTON (PRWEB) Aug... |
| Jun 15, 2022 | Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology Is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter | The Parent's Guide to Cord Blood features Asymmetrex's technology for determining the dosage of therapeutic cord blood stem cells. ...will help both non-experts and experts to understand how Asymmetrex counts therapeutic tissue st... |
| Jun 9, 2022 | Asymmetrex Presents New Developments in its Rapid Stem Cell Counting Technology at the ARMI|BioFabUSA Meeting in the Millyard on Regenerative Medicine Biomanufacturing | Asymmetrex reports algorithms for rapid quantification of therapeutic stem cells "Determining the dose of therapeutic stem cells is now more than just possible for the first time. With ARMI’s support it's getting easy to do, too!&... |
| May 31, 2022 | Asymmetrex CEO Publishes New Book on Missing Elements of U.S. COVID Science | The New Book Whether you are talking about stem cell science or COVID science, maintaining the highest level of scientific and ethical integrity are the most important things.
BOSTON (PRWEB) May 31, 2022
James L. Sherley, M.D., Ph.D. is bet... |
| Apr 14, 2022 | Asymmetrex Issued U.S. Trademark Registration for Business Name | Asymmetrex is now a registered trademark. "The new future is calculators that convert these common cell measurements into tissue stem cell-specific fraction and tissue stem cell-specific dosage. That future is here now with our new tra... |
| Feb 22, 2022 | Asymmetrex Describes How Advancing to Stem Cell-Specific Dosing May Begin with Veterinary Stem Cell Treatments | Asymmetrex describes how stem cell-specific dosing in veterinary medicine can promote improved stem cell treatments for people ...the field of veterinary stem cell medicine should lead the way for human stem cell medicine by implementing KS... |
| Sep 9, 2021 | See the biotech and pharma companies that are growing the fastest and pay workers the most | A scientist lowers biological samples into a liquid nitrogen storage tank. Dan Kitwood/Getty Images/Cancer Research UK
Insider compiled data on the fastest-growing biotech and pharma companies.
We examined how much they’re paying employees ... |
| Aug 25, 2021 | Massachusetts biopharmas claim state's 3rd-largest VC funding year on record in a single quarter at $4.3B | If you're going to call one state home, make it Massachusetts, says a host of biopharma startups that raised an eye-popping $4.3 billion in venture capital cash in just one quarter.
The first quarter haul for the New England state is c... |
| Aug 25, 2021 | Massachusetts biopharmas claim state's 3rd-largest VC funding year on record in a single quarter at $4.3B | If you're going to call one state home, make it Massachusetts, says a host of biopharma startups that raised an eye-popping $4.3 billion in venture capital cash in just one quarter.
To put that number in perspective, the overall biopha... |
| Aug 11, 2021 | Asymmetrex Plans to Review Tissue Stem Cell Reports That Need Stem Cell Counting | Asymmetrex introducing new stem cell medicine resource Sept. 8 "Patients are waiting for better stem cell medicines; and better stem cell medicines can only be had if we advance to better stem cell science."
BOSTON (PRWEB) August ... |
| Jun 15, 2021 | Asymmetrex Interviewed by SuperbCrew About Upcoming Presentations at ISSCR 2021 | Asymmetrex will be exhibiting and presenting at ISSCR 2021 for the first time. ...we have something of great value to share with the ISSCR community that will accelerate progress in research and medicine with adult tissue stem cells.
BOSTON... |
| May 20, 2021 | Asymmetrex Introduces Therapeutic Stem Cell Dosage Technologies to Biotherapeutics Bioprocessing Companies | "...it just makes good science, good medicine, and good sense to start using stem cell-specific dosage.”
BOSTON (PRWEB) May 20, 2021
Leading off the morning’s presentations in MarketsandMarkets’ Virtual 5th Annual Bioprocessing of Biot... |
| May 11, 2021 | Asymmetrex Discusses a Near Horizon for Stem Cell Dosage in Stem Cell Therapy and Gene Therapy Clinical Trial Supply Chains | Asymmetrex addresses the need for stem cell dosage data throughout supply chains for stem cell and gene therapy clinical trials. "A solution on the present horizon."
BOSTON (PRWEB) May 11, 2021
Leading off this morning’s presentat... |
| May 6, 2021 | Asymmetrex Will Discuss the Impact of Its Technology for Dosing Therapeutic Stem Cells | Asymmetrex President & CEO James L. Sherley, M.D., Ph.D. It’s basic medicine. Finally knowing the stem cell dosage of stem cell treatments must necessarily be better for patients.
BOSTON (PRWEB) May 06, 2021
The President and CEO of Mas... |
| Mar 25, 2021 | Asymmetrex Describes How New Technologies for Quantifying Stem Cell Dosage Will Improve the Effectiveness of the Stem Cell Clinical Trial Supply Chain | The Stem Cell Dosage Knowledge Gap “If dose is an essential principle in medicine, then it is also an essential requirement in stem cell medicine.”
BOSTON (PRWEB) March 25, 2021
The 2021 Virtual Conference on Clinical Trial Supply-Europe, o... |
| Feb 11, 2021 | More Than 100 Companies Adopt eClinical Solutions’ elluminate® Clinical Data Platform to Increase Clinical Trial Efficiency | "With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatments to patients," ... |
| Dec 14, 2020 | MassBio head Coughlin set to step down after overseeing massive biopharma expansion in the state during 13-year tenure | The past decade has been good to biopharma, nowhere more so than the bustling and ever-expanding life sciences hub in and around Boston. At the tip of the spear of that expansion is nonprofit trade association MassBio and its ... |
| Mar 26, 2020 | Strategic Planning In Biotech During A Pandemic Crisis | Life scientists researching in laboratory. Getty |
| Aug 2, 2019 | A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number | Health economists walk a precarious tightrope: Their analyses are quantitative and, presumably, emotion-free. But health care is intensely personal — and often, intensely emotional.
That tension between between quantitative analyses and liv... |
| Aug 29, 2018 | Massachusetts accounted for more than one-third of biopharma VC funding last year, report shows | Along with such a large share of venture capital, Massachusetts also accounted for the largest share of biotech initial public offerings, with 48 percent of all biotech companies having IPOs in 2017 being based in the state, compared with 3... |
| Mar 23, 2018 | Director of diversity and inclusion arrives at MassBio; Jerome Jabbour takes the helm at Matinas; Ex-Eli Lilly CFO becomes president of PBM business | Edie Stringfellow
→ In a first, the Massachusetts Biotechnology Council has brought on Edie Stringfellow as its director of diversity and inclusion, bolstering its initiative to improve inclusion and diversity in t... |
| Jan 16, 2018 | The J.P. Morgan Healthcare Conference in the #MeToo era | It’s such a weird time. We have all this #MeToo stuff going on and, at the same time, we as women are unsure how to proceed. Men are completely flummoxed. I have had conversations recently with men I view as rational and entirely un-sexist ... |
| Jan 5, 2018 | Term Sheet — Friday, January 5 | THE BILLIONAIRE CLUB
Happy Friday, Term Sheet readers!
Paid Content Securing the enterprise without boundaries From ExtraHop
Things changed this week. Kalanick plans to sell 29% of his stake in Uber. This means the ex-CEO will sell equity w... |
| May 23, 2017 | MassChallenge Boston Announces 2017 Cohort | BOSTON, MAY 23, 2017 - MassChallenge, the most startup-friendly accelerator on the planet, today announced the 128 early-stage startups that have been accepted into the 2017 MassChallenge Boston accelerator program. Selected by a community ... |
| Jan 12, 2017 | 10 surefire ways to improve gender diversity in biopharma | In some of the leading biotech and pharmaceutical companies, the majority of employees are women. More than half of new PhDs in the life sciences are women. And women are more likely to start companies than men. They are often the ones runn... |
| Jan 6, 2010 | MassMEDIC, UK medical device trade group ink promotional deal | MassMEDIC is making inroads across the pond.
The Massachusetts Medical Device Industry Council and one of its British counterparts, the Golden Triangle Partnership, inked a cross-promotion deal aimed at boosting the medical device industry’... |
| Nov 9, 2007 | Bind Biosciences, My IPO Prediction, and Brain Overload at MassOpps | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
I just got back from MassOpps—a life sciences PowerPointapalooza put on by the Massachusetts Biotechnology Council—and boy my brain is tired. In conference rooms at the Logan ... |
| Oct 1, 2007 | Life sciences briefing: Monday, Oct. 1, 2007 | Featured companies: Abiant, CellXplore, Diffusion Pharmaceuticals, WMR Biomedical, Zosano Pharmaceuticals
Diffusion Pharma raises $4.5M for vascular-disease and brain-cancer drug — Charlottesville, Va.-based Diffusion Pharmaceuticals, a bio... |
| Sep 17, 2007 | Good News and Bad News for University Endowments, ImClone and Repligen Reach Settlement, Venture Deals, Mergers, Acquisitions, and More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Last week left us with lots to talk about, so let’s get right to it.
—In venture news, RFID infrastructure firm Tagsys of Cambridge, MA, closed a $16 million second tranche of... |
| Aug 27, 2007 | Merger Brewing Between New England Energy Innovation Collaborative, Clean Energy Council | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The “green” energy business is growing so quickly in Massachusetts that it will soon leapfrog textiles to become Massachusetts’ 10th-largest industry, according to a survey re... |
| The J.P. Morgan Healthcare Conference in the #MeToo era | There were so many interesting themes from the JP Morgan conference this year that I wasn’t sure what story I wanted to tell first: the focus on oncology, the rush of pharma to digital, the newfound interest in social determinants of health... |
| Massachusetts accounted for more than one-third of biopharma VC funding last year, report shows | More than one-third of all venture capital funding for biopharma went to companies in one state, according to a report released Wednesday.
The report, by Massachusetts Biotechnology Council, also known as MassBio, found that 37 percent of a... |
